Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review

  • ID: 4308201
  • SWOT Analysis
  • 46 pages
  • GlobalData
  • Athersys Inc
1 of 5

FEATURED COMPANIES

  • Arena Pharmaceuticals Inc
  • Celgene Corp
  • Cytori Therapeutics Inc
  • Mesoblast Ltd
  • Pfizer Inc
  • Vericel Corp
  • MORE
Athersys Inc (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Athersys Inc (Athersys) is a biotechnology company, which carries out the discovery and development of novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as cardiovascular diseases, inflammatory and immune disorders, neurological conditions and others. Its MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, bone marrow/hematopoietic stem cell transplantation, ischemic stroke and autoimmune disease. Its other program, 5HT2c agonist is used for treating obesity and other conditions such as schizophrenia. Athersys is headquartered in Cleveland, Ohio, the US.

Athersys Inc Key Recent Developments

May 09,2017: Athersys Reports First Quarter 2017 Results
May 03,2017: Athersys Partnering With MedCision on High-Volume ThawSTAR Cell Thawing Systems for Use in Clinical Trials
Mar 09,2017: Athersys Reports Financial Results for Fourth Quarter, Full Year 2016
Nov 09,2016: Athersys Reports Third Quarter 2016 Results
Aug 09,2016: Athersys Reports Second Quarter 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Arena Pharmaceuticals Inc
  • Celgene Corp
  • Cytori Therapeutics Inc
  • Mesoblast Ltd
  • Pfizer Inc
  • Vericel Corp
  • MORE
Section 1 - About the Company
Athersys Inc - Key Facts
Athersys Inc - Key Employees
Athersys Inc - Key Employee Biographies
Athersys Inc - Major Products and Services
Athersys Inc - History
Athersys Inc - Company Statement
Athersys Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Athersys Inc - Business Description
Athersys Inc - Corporate Strategy
Athersys Inc - SWOT Analysis
SWOT Analysis - Overview
Athersys Inc - Strengths
Athersys Inc - Weaknesses
Athersys Inc - Opportunities
Athersys Inc - Threats
Athersys Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Athersys Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
May 09, 2017: Athersys Reports First Quarter 2017 Results
May 03, 2017: Athersys Partnering With MedCision on High-Volume ThawSTAR Cell Thawing Systems for Use in Clinical Trials
Mar 09, 2017: Athersys Reports Financial Results for Fourth Quarter, Full Year 2016
Nov 09, 2016: Athersys Reports Third Quarter 2016 Results
Aug 09, 2016: Athersys Reports Second Quarter 2016 Results
May 05, 2016: Athersys Reports First Quarter 2016 Results
Mar 10, 2016: Athersys Reports Fourth Quarter and 2015 Annual Results

Section 6 - Appendix
Methodology
Ratio Definitions
About the Publisher
Contact Us
Disclaimer

List of Tables:
Athersys Inc, Key Facts
Athersys Inc, Key Employees
Athersys Inc, Key Employee Biographies
Athersys Inc, Major Products and Services
Athersys Inc, History
Athersys Inc, Subsidiaries
Athersys Inc, Key Competitors
Athersys Inc, Ratios based on current share price
Athersys Inc, Annual Ratios
Athersys Inc, Annual Ratios (Cont...1)
Athersys Inc, Interim Ratios
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Athersys Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures:
Athersys Inc, Performance Chart (2012 - 2016)
Athersys Inc, Ratio Charts
Athersys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Athersys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Vericel Corp
  • Pfizer Inc
  • Mesoblast Ltd
  • Cytori Therapeutics Inc
  • Cryo-Cell International Inc
  • Celgene Corp
  • Astellas Institute for Regenerative Medicine
  • Arena Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll